New York State Common Retirement Fund
ORKA

New York State Common Retirement Fund’s Oruka Therapeutics ORKA Stock Holding History

New York State Common Retirement Fund’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.68M Buy
17,700
+5,500
+45% +$366K ﹤0.01% 1534
2026
Q1 		$598K Buy
12,200
+3,600
+42% +$125K ﹤0.01% 1844
2025
Q4 		$261K Hold
8,600
– – ﹤0.01% 2178
2025
Q3 		$165K Hold
8,600
– – ﹤0.01% 2384
2025
Q2 		$96.4K Buy
+8,600
New +$89.6K ﹤0.01% 2701

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

New York State Common Retirement Fund's ORKA Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Oruka Therapeutics (ORKA) stake by 45% in Q2 2026, buying an estimated $366K and bringing the position to 17,700 shares worth $1.68M. The position accounts for ﹤0.01% of the portfolio, ranked #1534.

New York State Common Retirement Fund first reported a position in ORKA in Q2 2025 and has held it in 5 quarters since. 255 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • New York State Common Retirement Fund held 17,700 shares of Oruka Therapeutics worth $1.68M as of Q2 2026.
  • New York State Common Retirement Fund bought 5,500 Oruka Therapeutics shares in Q2 2026, an estimated $366K.
  • Oruka Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #1534 holding.
  • New York State Common Retirement Fund first reported a position in Oruka Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 255 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.